TY - JOUR
T1 - Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC)
AU - Sobajima, J.
AU - Ozaki, S.
AU - Uesugi, H.
AU - Osakada, F.
AU - Shirakawa, H.
AU - Yoshida, M.
AU - Nakao, K.
PY - 1998
Y1 - 1998
N2 - In a previous study, we reported that the high mobility group (HMG) non- histone chromosomal proteins HMG1 and HMG2 were novel target antigens of P- ANCA. In this study, we determined the immunodiagnostic value of anti- HMG1/HMG2 antibodies in patients with UC. Sixty sera from patients with UC were tested for reactivity with HMG1 and HMG2 by means of ELISA. Anti-HMG1 antibody was detected in 32% of patients (40% of P-ANCA+ patients). Anti- HMG2 antibody was detected in 33% (40% of P-ANCA+ patients). Thirty-five percent of sera were positive for antibody to either HMG1 or HMG2 (43% of P- ANCA+ patients). P-ANCA+ patients expressed anti-HMG1/HMG2 antibodies with significantly greater frequency compared with P-ANCA- patients. Furthermore, the anti-HMG1/HMG2 antibodies were significantly related to disease activity in UC. Sixteen of the 18 UC patients, who had high titres of anti-HMG1 or - HMG2 antibody during the active phase, showed lower titres in the inactive phase. Anti-HMG1/HMG2 antibodies appear to be useful as a marker for disease activity in UC.
AB - In a previous study, we reported that the high mobility group (HMG) non- histone chromosomal proteins HMG1 and HMG2 were novel target antigens of P- ANCA. In this study, we determined the immunodiagnostic value of anti- HMG1/HMG2 antibodies in patients with UC. Sixty sera from patients with UC were tested for reactivity with HMG1 and HMG2 by means of ELISA. Anti-HMG1 antibody was detected in 32% of patients (40% of P-ANCA+ patients). Anti- HMG2 antibody was detected in 33% (40% of P-ANCA+ patients). Thirty-five percent of sera were positive for antibody to either HMG1 or HMG2 (43% of P- ANCA+ patients). P-ANCA+ patients expressed anti-HMG1/HMG2 antibodies with significantly greater frequency compared with P-ANCA- patients. Furthermore, the anti-HMG1/HMG2 antibodies were significantly related to disease activity in UC. Sixteen of the 18 UC patients, who had high titres of anti-HMG1 or - HMG2 antibody during the active phase, showed lower titres in the inactive phase. Anti-HMG1/HMG2 antibodies appear to be useful as a marker for disease activity in UC.
KW - Anti-neutrophil cytoplasmic antibodies
KW - HMG1
KW - HMG2
KW - Ulcerative colitis
UR - http://www.scopus.com/inward/record.url?scp=0031887801&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031887801&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2249.1998.00491.x
DO - 10.1046/j.1365-2249.1998.00491.x
M3 - Article
C2 - 9486411
AN - SCOPUS:0031887801
SN - 0009-9104
VL - 111
SP - 402
EP - 407
JO - Clinical and Experimental Immunology
JF - Clinical and Experimental Immunology
IS - 2
ER -